Skip to main content
Log in

Early treatment with cinacalcet is more cost effective than delayed treatment for patients with hyperparathyroidism secondary to renal failure,

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Ray J, Borker R, Barber B, Valentine W, Belozeroff V, Palmer A.Cost-effectiveness of treating patients with cinacalcet early versus delaying treatment with cinacalcet for secondary hyperparathyroidism in patients with ESRD. American Journal of Kidney Diseases 49: 68, No. 4, Apr 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Early treatment with cinacalcet is more cost effective than delayed treatment for patients with hyperparathyroidism secondary to renal failure,. Pharmacoecon. Outcomes News 529, 11 (2007). https://doi.org/10.2165/00151234-200705290-00029

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705290-00029

Keywords

Navigation